These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33370969)

  • 21. Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen.
    Sconce EA; Kamali F
    Eur J Haematol; 2006 Dec; 77(6):457-62. PubMed ID: 17042764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
    Knudsen JF; Sokol GH
    Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England.
    Abohelaika S; Kamali F; Avery P; Robinson B; Kesteven P; Wynne H
    Age Ageing; 2014 Sep; 43(5):708-11. PubMed ID: 24947831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multivitamin supplement interaction with warfarin therapy.
    Ducharlet KN; Katz B; Leung S
    Australas J Ageing; 2011 Mar; 30(1):41-2. PubMed ID: 21395940
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharyngeal haematoma and partial airway obstruction caused by interaction between warfarin and topical miconazole gel.
    Reynolds H
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33653857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of well managed warfarin. A report from the Swedish quality register Auricula.
    Sjögren V; Grzymala-Lubanski B; Renlund H; Friberg L; Lip GY; Svensson PJ; Själander A
    Thromb Haemost; 2015 Jun; 113(6):1370-7. PubMed ID: 25716771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.
    Pan KL; Singer DE; Ovbiagele B; Wu YL; Ahmed MA; Lee M
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28720644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants.
    Liew A; Eikelboom JW; O'Donnell M; Hart RG
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S34-44. PubMed ID: 23790596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An unusual presentation of spontaneous sub-conjunctival haematoma in a patient receiving warfarin.
    Shaikh M; Bodla AA
    Clin Exp Optom; 2006 May; 89(3):169-70. PubMed ID: 16637972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin.
    Woods K; Douketis JD; Kathirgamanathan K; Yi Q; Crowther MA
    J Thromb Thrombolysis; 2007 Oct; 24(2):93-7. PubMed ID: 17380255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bleeding risks and response to therapy in patients with INR higher than 9.
    Pagano MB; Chandler WL
    Am J Clin Pathol; 2012 Oct; 138(4):546-50. PubMed ID: 23010709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High intra- and inter-individual variability of plasma vitamin K concentrations in patients with atrial fibrillation under warfarin therapy.
    Kim YE; Woo HI; On YK; Kim JS; Lee SY
    Eur J Clin Nutr; 2015 Jun; 69(6):703-6. PubMed ID: 25828628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal warfarin-associated intracranial hemorrhage in atrial fibrillation inpatients.
    Chopard R; Piazza G; Hurwitz S; Fanikos J; Goldhaber SZ
    J Thromb Thrombolysis; 2019 Feb; 47(2):331-335. PubMed ID: 30449000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of vitamin K in patients on anticoagulant therapy: a practical guide.
    Hanslik T; Prinseau J
    Am J Cardiovasc Drugs; 2004; 4(1):43-55. PubMed ID: 14967065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.
    Crowther MA; Julian J; McCarty D; Douketis J; Kovacs M; Biagoni L; Schnurr T; McGinnis J; Gent M; Hirsh J; Ginsberg J
    Lancet; 2000 Nov; 356(9241):1551-3. PubMed ID: 11075768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial.
    Crowther MA; Douketis JD; Schnurr T; Steidl L; Mera V; Ultori C; Venco A; Ageno W
    Ann Intern Med; 2002 Aug; 137(4):251-4. PubMed ID: 12186515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical drainage of spontaneous sublingual haematoma.
    Hamilton A; Beardsley C
    BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35680279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
    Szummer K; Gasparini A; Eliasson S; Ärnlöv J; Qureshi AR; Bárány P; Evans M; Friberg L; Carrero JJ
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28249846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial.
    Marcatto LR; Sacilotto L; Bueno CT; Facin M; Strunz CM; Darrieux FC; Scanavacca MI; Krieger JE; Pereira AC; Santos PC
    BMC Cardiovasc Disord; 2016 Nov; 16(1):224. PubMed ID: 27855643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.